News by Tag: Gsk
FDA approves GSK's drug Horizant for a new cure
June 23, 2012
The fact that FDA has approved the novel use of Horizant, a drug manufactured by both XenoPort and GSK as a remedial option for post-herpetic neuralgia, a condition afflicting one-tenth of individuals suffering from shingles is really commendable.
June 23, 2012
The fact that FDA has approved the novel use of Horizant, a drug manufactured by both XenoPort and GSK as a remedial option for post-herpetic neuralgia, a condition afflicting one-tenth of individuals suffering from shingles is really commendable.